| 48.35 Delayed Data As of Mar 20 |  -0.89 / -1.81%Today’s Change | 36.28 Today|||52-Week Range 84.94 | +24.77% Year-to-Date |
| Previous close | 49.24 |
| Today’s open | 49.09 |
| Day’s range | 48.00 - 49.25 |
| Volume | 902,172 |
| Average volume (3 months) | 1,751,661 |
| Market cap | $6.5B |
| Earnings growth (last year) | -8.14% |
| Earnings growth (this year) | -4.14% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -4.31% |
| P/E ratio | 50.9 |
| Price/Sales | 1.13 |
| Price/Book | 1.15 |
| Today’s change | Today’s % change | |
|---|---|---|
| RDYDr.Reddy's Laborator... | +0.95 | +2.40% |
| CTLTCatalent Inc | -0.22 | -0.52% |
| JAZZJazz Pharmaceuticals... | -1.98 | -1.46% |
| GRFSGrifols SA | -0.14 | -0.73% |
| Next reporting date | May 7, 2019 |
| EPS forecast (this quarter) | $1.08 |
| Annual revenue (last year) | $4.7B |
| Annual profit (last year) | $131.0M |
| Net profit margin | 2.77% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Murray S. Kessler |
Executive VP- Global Operations and Supply Chain Ronald Janish |
Corporate headquarters Dublin, Dublin |
